⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 1, 2009Nanomedicine

Pharmaceutical Stability Aspects of Nanomedicines

Madaswamy S. Muthu Si‐Shen Feng

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

10.2217/nnm.09.75

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Muthu et al. (2009) studied this question.

synapsesocial.com/papers/6aa95abb398b99bbe68cc53f https://doi.org/10.2217/nnm.09.75

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Evaluation of a bismuth-ellagic acid metal-organic framework for the prophylaxis of inflammatory disordersNanomedicine · Thu,
2The role of nanomedicine in infectious diseases of the central nervous system: a narrative reviewNanomedicine · Sat,
3Porous nanofibrous microspheres: synthesis approaches and applications to tissue regenerationNanomedicine · Sun,
4Multimodal nanoengineered scaffolds as regenerative microenvironment orchestrators: coupling mechanical, bioelectrical, immunological, and spatiotemporal therapeutic cuesNanomedicine · Wed,
5mRNA-based nanomedicine for diabetic wound repair: advances in LNP delivery, immune modulation, and regenerative pathwaysNanomedicine · Fri,

More from Nanomedicine

Neuroprotective effects of lithium and caffeic acid co-loaded liposomes in diabetes-induced Alzheimer’s disease: association with GSK-3β and β-cateninSat,
New approach methodologies to model the female reproductive tract: advances and opportunities for nanomedicineSun,
Cardiac nanomedicine for ischemic injury and remodeling: imaging and therapySun,
Heat-preconditioned MSC-derived exosomal miR‑486‑5p reverses doxorubicin resistance in breast cancerThu,
Sensitizing nanomedicine for platinum-resistant ovarian cancerMon,